[1]
“Comparative Efficacy and Safety of Anti-VEGF Agents in Neovascular Age-Related Macular Degeneration: A Meta-Analysis”, OAIJMR, vol. 5, no. 1, pp. 69–82, Mar. 2025, doi: 10.37275/oaijmr.v5i1.723.